The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CNS-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: Final analysis of a phase II study.
Agnieszka Korfel
Research Funding - Mundipharma
Gerald Illerhaus
No relevant relationships to disclose
Mathias Haenel
No relevant relationships to disclose
Robert Moehle
No relevant relationships to disclose
Roland Schroers
No relevant relationships to disclose
Thomas Elter
No relevant relationships to disclose
Marcel Reiser
No relevant relationships to disclose
Martin H. Dreyling
No relevant relationships to disclose
Jan Eucker
No relevant relationships to disclose
Christian Winfried Scholz
No relevant relationships to disclose
Bernd Metzner
No relevant relationships to disclose
Alexander Roeth
No relevant relationships to disclose
Josef Birkmann
No relevant relationships to disclose
Uwe S. Schlegel
No relevant relationships to disclose
Peter Martus
No relevant relationships to disclose
Eckhard Thiel
No relevant relationships to disclose
Lars Fischer
Research Funding - Mundipharma